Why the future of structure-based drug discovery depends on better benchmarking for pose and activity prediction.

by Dr. Neil Taylor

There’s a direct link from the 2024 No...

READ MORE

Exploring the structural and computational advances shaping the future of antibody therapies.

Over the past decade, breakthroughs in antibody engineering have redefined what's possible in ...

READ MORE

How AI and ML are changing the game

by Dr. Neil Taylor

Artificial intelligence is rapidly redefining what’s possible in ligand design. In this article, we explore recent brea...

READ MORE